1. 10 Multiplex genotyping of matched EBUS TBNA and cfDNA samples in advanced NSCLC patients. (January 2016) Authors: Lyons, J.; O'Brien, C.; Krussel, S.; Finn, S.P.; Cuffe, S.; O'Connell, F.; Gately, K. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1233 Hepatitis screening in solid tumours: Results in an Irish cancer centre. (September 2015) Authors: Ged, Y.; Crowley, B.; Cuffe, S.; Harrold, E.; Keegan, N.M.; Kennedy, M.J.; Mustafa, M.; Norris, S.; O'Donnell, D.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2: Platinum-induced DNA damage and repair mechanisms in non-small cell lung cancer. (January 2015) Authors: He, Y.; O'Byrne, K.J.; Cuffe, S.; Finn, S.; Barr, M. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2: XRCC6BP1: A key player in cisplatin resistance and lung cancer stem cells. (January 2017) Authors: Barr, M.P.; Singh, S.; Foley, E.; He, Y.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; O'Byrne, K.J.; Cuffe, S.; Finn, S. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3BA A phase II trial of erlotinib (E) and bevacizumab (B) in patients with advanced non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations with and without T790M mutation. The Spanish Lung Cancer Group (SLCG) and the European Thoracic Oncology Platform (ETOP) BELIEF trial. (September 2015) Authors: Stahel, R.A.; Dafni, U.; Gautschi, O.; Felip, E.; Curioni-Fontecedro, A.; Peters, S.; Massutí, B.; Cardenal, F.; Aix, S.P.; Früh, M.; Pless, M.; Popat, S.; Kotsakis, A.; Cuffe, S.; Bidoli, P.; Favaretto, A.; Carcereny, E.; Sanchez Ronco, M.; Molina, M.A.; Rosell, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 4 Identification and targeting of the DNA repair gene, XRCC6BP1, in cisplatin resistant NSCLC. (January 2016) Authors: Barr, M.P.; Foley, E.; He, Y.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; O'Byrne, K.J.; Finn, S.P.; Cuffe, S. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer. (January 2015) Authors: Baird, A.-M.; Godwin, P.; Heavey, S.; Barr, M.; Umezawa, K.; Cuffe, S.; Finn, S.; O'Byrne, K.J.; Gately, K.A. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 5 A novel microRNA signature associated with cisplatin resistant NSCLC holds both diagnostic and prognostic biomarker potential. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; Yin Sui, J. Sze; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 56: Multiple RTK targeting as a therapeutic option in malignant pleural mesothelioma. (January 2017) Authors: Baird, A.; Easty, D.; Mohamed, B.M.; Jarzabek, M.; Shiels, L.; Soltermann, A.; Raeppel, S.; McDonagh, L.; Clarke, G.; Crosbie-Staunton, K.; Stanfill, B.; Nonaka, D.; Goparju, C.M.; Prina-Mello, A.; Volkov, Y.; Murer, B.; Fennell, D.A.; O'Donnell, D.M.; Mutti, L.; Barr, M.P. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 5: Mechanisms of resistance to dual PI3K–mTOR inhibition in NSCLC cell lines. (January 2015) Authors: Heavey, S.; Dowling, P.; Barr, M.; Cuffe, S.; Finn, S.; O'Byrne, K.J.; Gately, K.A. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗